Albert Edward Glasscock

Title: Albert Edward Glasscock: Innovator in Biomarkers for SUDEP

Introduction

Albert Edward Glasscock is a notable inventor based in Shreveport, Louisiana. He has made significant contributions to the field of medical technology, particularly in the area of biomarkers for determining susceptibility to Sudden Unexpected Death in Epilepsy (SUDEP). His innovative approach combines various data sources to assess patient risk effectively.

Latest Patents

Glasscock holds a patent for a method that determines an increased risk of death in patients. This method involves receiving ECG data generated during a specific time period and EEG data from the same period. By composing features from both data sets over a common time frame, he determines a statistical measure of association between the ECG and EEG data. If the degree of association exceeds a predetermined threshold, it indicates an increased risk of death. This patent is a significant advancement in patient care and risk assessment.

Career Highlights

Throughout his career, Glasscock has worked with esteemed institutions such as Louisiana State University and Agricultural & Mechanical College and Louisiana Tech Research Corporation. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.

Collaborations

Glasscock has collaborated with notable colleagues, including Leonidas D Iasemidis and Ioannis Vlachos. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Albert Edward Glasscock's contributions to the field of biomarkers for SUDEP highlight his dedication to improving patient outcomes through innovative technology. His work exemplifies the impact that a single inventor can have on medical science and patient care.